David Happel's Net Worth
David Happel's net worth is estimated to be at least $727,829.00 as of 03/05/2026. CoreStreet's estimation of David Happel's net worth is based on their sale of stock and current holding of stock.
David Happel is CEO at Sagimet Biosciences Inc. Series A Common Stock. They have executed at least 4 trades of stock as per SEC Form 4 filings. Their most recent trade was for 12,101 units of SGMT stock on 02/10/2026. Their biggest sale was on 07/21/2025 when they sold 65,478 units of Sagimet Biosciences Inc. Series A Common Stock stock for $597,814.14. They typically trade 1 times per year.
Total value of insider buys:
- $65,153.50
Total value of insider sells:
- $662,675.50
Most recent insider trade:
- Feb. 10, 2026
David Happel's Insider Trading History
| Sagimet Biosciences Inc. Series A Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 10, 2026 | CEO | 12,101 | $5.36 | Sell | $64,861.36 |
July 21, 2025 | CEO | 65,478 | $9.13 | Sell | $597,814.14 |
March 26, 2024 | CEO | 12,100 | $5.27 | Buy | $63,767.00 |
Nov. 16, 2023 | CEO | 590 | $2.35 | Buy | $1,386.50 |